NRXP · NRX Pharmaceuticals, Inc. · Congressional Trades
$3.44
-0.03 (-0.74%)
At close · Sep 9
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$145.91M
Shares
43.30M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this listed security yet.
Key facts
CIK
1719406
CUSIP
629444209
13F (30d)
33 filings
33 filers
Visit website
Investor relations